Preparation and Characterization of Monensin Loaded PLGA Nanoparticles: In Vitro Anti-Malarial Activity Against Plasmodium Falciparum

2012 ◽  
Vol 8 (1) ◽  
pp. 172-181 ◽  
Author(s):  
Ranu Surolia ◽  
Manendra Pachauri ◽  
Prahlad Chandra Ghosh
2021 ◽  
Vol 11 (2) ◽  
pp. 109-120
Author(s):  
Salahuddin Salahuddin ◽  
Rahmana Emran K ◽  
Muhammad Hanafi ◽  
Andini Sundowo ◽  
Puspa Dewi NL ◽  
...  

Nowadays kinin is the most effective antimalarial drug and its used as an alternative in malaria treatment. However, toxicity of quinine restrict its use as an antimalarial drug. Lipophilicity and long half-life (t½) of quinine that reach 10-20 hours are responsible for its toxicity. The aim of this research is to obtain more polar quinine derivatives by means of hydrogen peroxide reactions to reduce the toxicity. The reactions using hydrogen peroxyde is performed analogously to the procedures reported in the literature. Extract of pure anhydrous kinin is purified in coloumn chromatography followed by structure elucidation. Synthetic product is tested in vitro against Plasmodium falciparum. The characterization of reaction products is performed with proton (1H) and carbon 13 (13C) nuclear magnetic resonance (NMR) spectroscopy. It showed that the reaction using reagents led to epoxidation of vinyl substituents of chinuclidine ring with 61,08% yields. Antimalarial test against Plasmodium falciparum obtained 1.250-2.500 μg/mL of IC50 value. The IC50 values indicated that the synthesis products were not potential for malaria treatment.


Nanomedicine ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. 663-677 ◽  
Author(s):  
Matija Rojnik ◽  
Petra Kocbek ◽  
Francesca Moret ◽  
Chiara Compagnin ◽  
Lucia Celotti ◽  
...  

2016 ◽  
Vol 511 (2) ◽  
pp. 719-727 ◽  
Author(s):  
Cristina Cañadas ◽  
Helen Alvarado ◽  
Ana C. Calpena ◽  
Amélia M. Silva ◽  
Eliana B. Souto ◽  
...  

2021 ◽  
Vol 12 (4) ◽  
pp. 482-487
Author(s):  
Bharat Patel ◽  
Satyendra Kumar Tripathi ◽  
Sandhya Pathak ◽  
Sandeep Shukla ◽  
Archna Pandey

Plasmodium falciparum is one of the most common resistant Plasmodium species responsible for high rates of morbidity and mortality in malaria patients. Clinical guidelines for the management of Plasmodium falciparum include the use of a dose of primaquine phosphate resulting intolerable side effects. Therefore, the aim of this work was to formulate primaquine phosphate-loaded PLGA nanoparticles by using a nanoprecipitation method in order to increase its bioavailability to minimize drug intake. This leads to reduced toxicity and better therapeutic efficacy of the drug. The synthesized nanoparticles were characterized by using dynamic light scattering (DLS), transmission electron microscopy (TEM), scanning electron microscopy (SEM), atomic force microscopy (AFM), Fourier transformed infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and powder X-ray diffraction (XRD). TEM analysis revealed the presence of smooth spherical-shaped nanoparticles. The drug DLS analysis confirmed the presence of negatively charged nanoparticles with particle size in the range of 100-400 nm. The drug release study was performed to analyses different kinetic models like zero-order model, first-order model, Higuchi model, Hixson-Crowell model, and Korsmeyer-Peppas model.


1998 ◽  
Vol 334 (2) ◽  
pp. 437-445 ◽  
Author(s):  
Matthew BERRIMAN ◽  
Alan H. FAIRLAMB

Cyclosporin (Cs) A has pronounced antimalarial activity in vitro and in vivo. In other organisms, the drug is thought to exert its effects either by inhibiting the peptidylprolyl cis/trans isomerase activity of cyclophilin (CyP) or by forming a CyP–CsA complex that inhibits the phosphatase activity of calcineurin. We have cloned and overexpressed in Escherichia coli a gene encoding a CyP from Plasmodium falciparum (PfCyP19) that is located on chromosome 3. The sequence of PfCyP19 shows remarkable sequence identity with human CyPA and, unlike the two previously identified CyPs from P. falciparum, PfCyP19 has no signal peptide or N-terminal sequence extension, suggesting a cytosolic localization. All the residues implicated in the recognition of the synthetic substrate N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide are conserved, resulting in characteristically high Michaelis–Menten and specificity constants (Km ≫ 120 µM, kcat/Km = 1.2×107 M-1·s-1 respectively). As the first line in the functional characterization of this enzyme, we have assessed its binding affinity for CsA. In accordance with its tryptophan-containing CsA-binding domain, PfCyP19 binds CsA with high affinity (Kd = 13 nM, Ki = 6.9 nM). Twelve CsA analogues were also found to possess Ki values similar to CsA, with the notable exceptions of Val2-Cs (Ki = 218 nM) and Thr2-Cs (Ki = 690 nM). The immunosuppressants rapamycin and FK506 were inactive as inhibitors, consistent with other members of the CyP family of rotamases. The CsA analogues were also assessed as inhibitors of P. falciparum growth in vitro. Although their antimalarial activity did not correlate with inhibition of enzyme activity, residues 3 and 4 of CsA appeared to be important for inhibition of parasite growth and residues 1 and 2 for PfCyP19 inhibition. We propose that a malarial CyP–CsA complex presents residues 3 and 4 as part of an ‘effector surface ’ for recognition by a downstream target, similar to the proposed mechanism for T-cell immunosuppression.


2003 ◽  
Vol 47 (1) ◽  
pp. 87-94 ◽  
Author(s):  
Pharath Lim ◽  
Sophy Chy ◽  
Frédéric Ariey ◽  
Sandra Incardona ◽  
Pektra Chim ◽  
...  

ABSTRACT Plasmodium falciparum chloroquine resistance was first detected in Cambodia in the early sixties. Treatment with chloroquine was abandoned 20 years ago. In vitro chloroquine sensitivity monitoring indicates that all eastern Cambodian isolates were sensitive to chloroquine, whereas most isolates collected from western provinces displayed reduced susceptibility to chloroquine. This indicates that the rate of chloroquine resistance remains high and stable in this region in the absence of chloroquine pressure. Characterization of codons 72 to 78 and 218 to 220 of pfcrt revealed six distinct haplotypes, four of which had never been described. The frequency of each haplotype depended on the geographical origin of the samples. The CVIETIF//ISS haplotype was detected in 92% of western Cambodian isolates and in 11% of isolates collected from the eastern province, where CVMNKIF//ISA and CVIDTIF//ISS predominate. The detection of an intermediate haplotype from a susceptible area with 76T/220A, suggests that acquisition of chloroquine resistance might be a stepwise process, during which accumulation of point mutations modulates the response to chloroquine. The association of the K76T mutation with chloroquine resistance was not clear. The mutation was detected in resistant and susceptible samples, suggesting that additional factors are involved in chloroquine resistance. By contrast, the pfcrt D/N75E mutation was strongly associated with the in vitro chloroquine resistance in Cambodian isolates. The N86 allelic form of pfmdr1 was detected in all isolates, consistent with a poor association with resistance to chloroquine. This indicates that in vitro resistance to chloroquine was associated with accumulation of point mutations in pfcrt.


Sign in / Sign up

Export Citation Format

Share Document